javier pinilla-ibarz, md, phd: principle treatment options for patients with a 17p deletion
Published 8 years ago • 196 plays • Length 0:59
Download video MP4
Download video MP3
Similar videos
-
1:12
javier pinilla-ibarz, md, phd: treatment options for patients with previously treated cll
-
1:08
javier pinilla-ibarz, md, phd - malignant hematology
-
0:45
javier pinilla-ibarz, md, phd: options to prolong survival
-
1:04
javier pinilla-ibarz, md, phd: additional chemo-immunotherapy
-
1:55
paul barr, md: principle treatment options for patients with a 17p deletion
-
0:47
javier pinilla-ibarz, md, phd: relapse following purine analog therapy
-
0:59
javier pinilla-ibarz, md, phd: use of bruton's tyrosine kinase inhibitor
-
58:22
a new historical model and periodization for the perception of the sunnah and his companions
-
5:39
donita's cml story
-
1:44
rodney j. kratz, m.d.
-
0:31
javier pinilla-ibarz, md, phd: phase iii data to support usage of bruton's tkis
-
0:54
javier pinilla-ibarz, md, phd: significance of treat to progression
-
0:47
javier pinilla-ibarz, md, phd: dose intensity
-
0:42
javier pinilla-ibarz, md, phd: bendamustine/rituximab therapy
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
1:48
dr. pinilla-ibarz on the role of chemotherapy in cll
-
0:52
dr. pinilla-ibarz discusses advancements in cml
-
5:06
treatment-free remission in cml
-
1:24
how ibrutinib has transformed the treatment paradigm of cll
-
1:14
dr. pinilla-ibarz on the impact of venetoclax in cll
-
2:09
phase ii trial of venetoclax monotherapy for relapsed/refractory cll with 17p deletion
-
6:28
ibrutinib for cll with deletion 17p
Clip.africa.com - Privacy-policy